North Carolina's Pharma/Biotech Capital Construction Project Activity Remains Strong, an Industrial Info Market Brief
Attachment: Map
North Carolina continues to see a surge of Pharmaceutical/Biotech construction activity. Major firms such as Merck, Eli Lilly, Pfizer and Grifols are either planting or expanding their manufacturing roots in the state. North Carolina's attraction can be attributed to its skilled workforce, state/local incentives, and proximity to other pharma/biotech firms.